Stay updated with breaking news from Andrewh Ko. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Second-line gemcitabine and paclitaxel can improve some outcomes over gemcitabine alone in patients with metastatic pancreatic cancer, phase 3 data suggest. Second-line GEMPAX can improve some outcomes over gemcitabine alone in patients with metastatic pancreatic cancer, phase 3 data suggest.
Adding atezolizumab to FLOT led to more downstaging, complete regressions versus chemo alone
Findings from the CheckMate 649 trial “further support the use of (Opdivo) plus chemotherapy as a tolerable and efficacious first-line treatment” for some patients, according to researchers.
In a pan-cancer analysis, patients with pancreatic acinar cell carcinoma had the highest prevalence of BRCA2 germline pathogenic variants.
In a pan-cancer analysis, patients with pancreatic acinar cell carcinoma had the highest prevalence of BRCA2 germline pathogenic variants.